YNHHS will integrate ActX Genomic Decision Support at its five hospitals and over 400 ambulatory sites, including its 1,541-bed academic medical center.
The ActX platform aims to help prescribers check prescription drugs against a patient’s genetic profile. With the clinical decision support tool, prescribers will receive alerts within their Epic workflow related to potential adverse reactions, drug efficacy or dosing.
YNHHS will initially focus its genomic decision support on pharmacogenomics in behavioral health, cardiology, infectious disease and pediatrics.
More articles on data analytics & precision medicine:
Wisconsin researchers awarded $5.3M for NIH All of Us program
Chicagoland hospital to offer genetic testing as part of an annual checkup
Illumina Accelerator, Helix team up to develop direct-to-consumer genomics products
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
